Centre Hospitalier Princesse Grace
Monaco, 98000
NCT Number: NCT05049551
The primary objective of this study is to evaluate the potential of a new large field CZT gamma camera to estimate the thyroid uptake (TU) on Single photon emission computed tomography (SPECT) and SPECT/CT images in comparison with standard planar scintigraphy.
The secondary objective is to analyze the diagnostic contribution of SPECT/CT imaging.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Monaco, 98000
Planar and SPECT/CT scintigraphy will be performed on a new generation large field CZT gamma camera and thyroid uptake (TU) value will be calculated on planar acquisition for 23 consecutive patients referred in our department for hyperthyroidism.
With a quantitative approach using attenuation, scatter correction and iterative algorithm with resolution recovery we will have the possibility to calculate the TU value with SPECT or SPECT/CT acquisitions.
Our primary objective will be to evaluate the potential of a new large field CZT gamma camera to estimate the thyroid uptake on SPECT (Tomography without attenuation correction) and SPECT/CT (tomography with attenuation correction) acquisitions compared with standard planar scintigraphy as a gold standard.
The secondary objective will be to analyze the diagnostic contribution of SPECT/CT images.
To established this study it will be necessary to introduce cross-calibration factors performed from a thyroid phantom, for planar and SPECT acquisitions, to estimate the thyroid uptake values.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Inclusion
Quantification of thyroid uptake
Time frame: Inclusion
Diagnostic contribution of SPECT/CT
Centre Hospitalier Princesse Grace
Other
Quantitative Analysis of 99mTc-Pertechnetate Thyroid Uptake With a Large Field CZT Gamma Camera: Feasibility and Comparison Between SPECT/CT and Planar Acquisitions
Acronym: QUANTHYC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06408909
Behavior, Endocrine System Diseases
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT05070091
Adrenal Gland Diseases, Adrenal Insufficiency
Gdansk, Poland
View Trial DetailsNCT02107794
Autoimmune Diseases, Behavior
Rochester, Minnesota, United States
View Trial DetailsNCT01727973
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Guangzhou, Guangdong, China
View Trial Details